Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

AstraZeneca progresses elecoglipron after positive phase IIb results

9th Jun 2026 08:09

(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

7th Jun 2026 16:01

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris. Read More

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

6th Jun 2026 09:11

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the Financial Times in an interview published on Saturday. Read More

LONDON MARKET CLOSE: FTSE 100 edges up while US jobs data lifts dollar

5th Jun 2026 17:05

(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expected jobs data increased chances of a rate hike across the pond. Read More

Worldwide Healthcare Trust outperforms benchmark; praises AstraZeneca

5th Jun 2026 10:06

(Alliance News) - Worldwide Healthcare Trust PLC on Friday said pharma company AstraZeneca PLC was its top contributor to its portfolio performance while surgical equipment firm Stryker Corp was the top detractor. Read More

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit

2nd Jun 2026 13:55

(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant. Read More

BSF Enterprise shares jump on paper in praise of "T-rex leather"

2nd Jun 2026 12:02

(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather products. Read More

AstraZeneca hails Imfinzi and Imjudo liver cancer trial results

1st Jun 2026 13:54

(Alliance News) - AstraZeneca PLC on Monday posted positive phase-three trial results for a combination of its drugs Imfinzi and Imjudo to treat a form of liver cancer. Read More

EARNINGS: Polar Capital Global Healthcare lags benchmark index

29th May 2026 16:42

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

AstraZeneca highlights data insights from Cares clinical programme

29th May 2026 14:35

(Alliance News) - AstraZeneca PLC on Friday announced that the CARES phase 3 clinical programme did not meet a primary endpoint, but noted insightful data. Read More

WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership

29th May 2026 11:34

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

CelLBxHealth shares jump on partnership with AstraZeneca

29th May 2026 10:31

(Alliance News) - CelLBxHealth PLC on Friday disclosed that it has entered a partnership with AstraZeneca PLC. Read More

LONDON MARKET OPEN: FTSE 100 climbs as US-Iran deal draws closer

29th May 2026 09:20

(Alliance News) - Stock prices in London opened higher on Friday, amid renewed hope for a deal between the US and Iran, which is reportedly awaiting the nod from President Donald Trump. Read More

LONDON BRIEFING: Ocado teams with Asda; AstraZeneca drug gets US nod

29th May 2026 07:56

(Alliance News) - Ocado Group strikes a deal with UK supermarket Asda, an AstraZeneca drug wins US approval to treat bladder cancer and Serabi Gold's first quarter profit more than doubles. Read More

AstraZeneca says FDA extends breast cancer drug review period

27th May 2026 08:29

(Alliance News) - AstraZeneca PLC on Wednesday said that the US Food & Drug Administration has extended the review period for its camizestrant filing to allow time for the assessment of additional data related to the breast cancer treatment. Read More

LONDON BRIEFING: Energy bills to rise 13%; Pets At Home cuts dividend

27th May 2026 07:56

(Alliance News) - The price cap for household energy bills in Great Britain is set to rise by 13% from July, Pets At Home reports lower earnings and cuts its dividend and AIB's chief financial officer steps down. Read More

AstraZeneca and Daiichi cancer drugs clear regulatory hurdles

22nd May 2026 15:48

(Alliance News) - AstraZeneca PLC on Friday announced one approval and two recommendations for three products, for different cancer indications, in the US and EU. Read More

CT UK Capital underperforms as underweight on AstraZeneca, Shell

22nd May 2026 11:02

(Alliance News) - CT UK Capital & Income Investment Trust PLC on Friday increased its dividend but said it underperformed the FTSE all-share index in the first half of its financial year. Read More

US regulator greenlights AstraZeneca's blood pressure drug Baxfendy

18th May 2026 09:47

(Alliance News) - AstraZeneca PLC on Monday reported US clearance for its hypertension treatment Baxfendy. Read More

12345678910
FTSE 100 Latest
Value10,347.70
Change-25.50